ArticleFrontiers in immunology2023

Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting.

James H A Clubb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.